Bioharvest Sciences (BHST) Invested Capital (2023 - 2025)

Bioharvest Sciences' Invested Capital history runs 3 years deep, the most recent figure standing at $25.6 million for Q4 2025.

• In Q4 2025, Invested Capital rose 388.96% year-over-year to $25.6 million; the TTM figure through Dec 2025 stood at $25.6 million (up 388.96% YoY), while the FY2025 annual figure was $25.6 million, up 388.96% from the prior year.
• Invested Capital was $25.6 million for Q4 2025 at Bioharvest Sciences, up from $3.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $25.6 million in Q4 2025 to a low of -$83.0 million in Q4 2023.
• Historically, Invested Capital has averaged -$3.4 million across 3 years, with a median of $5.2 million in 2024.
• Biggest YoY gain for Invested Capital was 388.96% in 2025; the steepest drop was 10.63% in 2025.
• A 3-year view of Invested Capital shows it stood at -$83.0 million in 2023, then surged by 106.31% to $5.2 million in 2024, then soared by 388.96% to $25.6 million in 2025.
• The last three Invested Capital figures came in at $25.6 million (Q4 2025), $3.7 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.